🔗 Share this article

A shadow economy for unapproved weight-loss medications is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.

Experimental Drug Gaining Traction Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Followers are encouraged to contact these accounts directly for supplier links, while also obtaining discount codes.

Active Trade on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where groups with thousands of members share comparison photos, administration instructions and claims of rapid British shipping. Vendors promote the drug there before redirecting buyers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.

Medical Experts Express Worries

However, doctors and chemists have warned that the distribution of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to users injecting substances of uncertain source.

Some professionals stated the demand for retatrutide could be connected to the increasing price of approved slimming treatments such as Mounjaro.

Legal Status and Enforcement

Marketing retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still breach medicines, advertising, and consumer regulations, potentially leading to fines, prosecution or imprisonment.

Service Response and Material Removal

Based on TikTok, the service has removed problematic content and prohibited associated hashtags and query recommendations. The organization said it was committed to keeping the platform safe and investing in strengthening enforcement strategies.

Online Marketplace Activities

Research also found communities with up to 9,000 participants marketing the experimental drug using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” immediately displays groups with thousands of users, populated with photos of slimming results, positive testimonials and detailed instructions for mixing or injecting at residence.

Within moments of entering one community, a vendor posted WhatsApp details, where most purchases take place. The vendor provided an instruction manual and guaranteed delivery within two days. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None asked about weight, health issues or previous experience.

Item Information and Costs

Within these communities, posts show dark colored packages with postal service stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with sterile water, or pre-filled pens usually sold at 160 pounds for 20mg. When asked how long a pen should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Safety Actions

A spokesperson for the messaging service said it actively moderated harmful material on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting substances they can’t verify. Although the research behind retatrutide is sound, these digital versions may not include what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in demand to current cost increases for authorized slimming medications such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.

Her staff has already encountered patients injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your health,” stated Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Consequently at this point no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company investigational product not yet approved … may subject patients to possibly significant health risks”.